Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non–Small-Cell Lung Cancer Data Set

Lignende værker

• Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer
  af: Griffith, Sandra D., et al.
  Udgivet: (2019)
•  Author’s Response to “A Letter in Support of Real-World RECIST”
  af: Griffith, Sandra D., et al.
  Udgivet: (2020)
• An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer
  af: Stewart, Mark, et al.
  Udgivet: (2019)
• Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer
  af: Kehl, Kenneth L., et al.
  Udgivet: (2021)
• Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points
  af: Lee, L., et al.
  Udgivet: (2011)